ANRS, Emerging Infectious Diseases

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website

Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence

First Posted Date
2012-01-13
Last Posted Date
2016-07-21
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
28153
Registration Number
NCT01509508
Locations
🇿🇦

Hlabisa Hospital, Hlabisa, KwaZulu-Natal, South Africa

Lipopeptide Immunisation With GTU-multiHIV Trial

First Posted Date
2011-12-15
Last Posted Date
2019-07-05
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
103
Registration Number
NCT01492985
Locations
🇫🇷

Service d'Immunologie clinique, Centre de vaccination anti-VIH ANRS Mondor Ile-de-France, Hôpital Henri Mondor, Créteil, France

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-11-17
Last Posted Date
2017-05-11
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
400
Registration Number
NCT01473472
Locations
🇫🇷

CHU Hôtel Dieu, Nantes, France

🇫🇷

Hôpital de l'Archet, Nice, France

🇫🇷

Hôpital Gustave Dron, Tourcoing, France

and more 4 locations

Renal Transplantation and Raltegravir in HIV-Infected Patients

First Posted Date
2011-10-17
Last Posted Date
2016-07-12
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
27
Registration Number
NCT01453192
Locations
🇫🇷

Hôpital Kremlin Bicêtre, Service de Néphrologie, Kremlin Bicêtre, France

🇫🇷

Hôpital Henri Mondor, Service de Néphrologie Transplantation, Créteil, France

🇫🇷

CHRU Lille, Service de néphrologie, Lille, France

and more 11 locations

Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

First Posted Date
2011-08-19
Last Posted Date
2015-07-24
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
48
Registration Number
NCT01420523
Locations
🇫🇷

Hôpital Pitié Salpétrière, Paris, France

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

First Posted Date
2011-05-05
Last Posted Date
2016-07-12
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
407
Registration Number
NCT01348308
Locations
🇫🇷

Hôpital Henri Mondor, Creteil, France

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

First Posted Date
2011-04-14
Last Posted Date
2014-10-13
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
69
Registration Number
NCT01335529
Locations
🇫🇷

CHU Sainte Marguerite, Marseille, France

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

First Posted Date
2011-04-11
Last Posted Date
2014-01-23
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
70
Registration Number
NCT01332955
Locations
🇫🇷

Service Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Lyon, France

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)

Not Applicable
Completed
Conditions
First Posted Date
2011-04-08
Last Posted Date
2015-08-05
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
441
Registration Number
NCT01331811
Locations
🇧🇫

CHU Sourô Sanou, Bobo Dioulasso, Burkina Faso

🇰🇭

National Pediatric Hospital, Phnom Penh, Cambodia

🇨🇲

Centre Hospitalier d'Essos, Yaounde, Cameroon

and more 5 locations

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Phase 3
Withdrawn
Conditions
Interventions
First Posted Date
2010-12-07
Last Posted Date
2012-11-08
Lead Sponsor
ANRS, Emerging Infectious Diseases
Registration Number
NCT01255371
Locations
🇹🇿

NIMR-Mbeya Medical Research Program-Mbeya Referral Hospital, Mbeya, Tanzania

🇿🇦

Tshepang clinic, Limpopo University, Pretoria, South Africa

© Copyright 2024. All Rights Reserved by MedPath